Neuracle Science
PrivateLast Round
Private Placement
May 13, 2024
Est. Valuation
$54.56M
Total Funding Raised
$47.82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neuracle Science is a biopharmaceutical company that develops antibody therapeutics for the treatment of neurodegenerative and sensory nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuracle Science Comparables
Compare Neuracle Science with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alector | 74% | |
| Acousia Therapeutics GmbH | 72% | |
| Strekin AG | 68% | |
Neuracle Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | May 13, 2024 | ||||
| Series C | Jun 13, 2019 | ||||
| Series B | Aug 14, 2018 |
Key People
Founding team and executive leadership
Neuracle Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seven Tree Equity Partners | Series C |
| Shinhan Securities | Series C |
| BNK Asset Management | Series C |
| Arche Investment | Series B, Private Placement, Series C |
| Industrial Bank of Korea | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors grew 54% MoM, reaching 3K.
- Jun 1, 2025
Monthly visitors grew 233% MoM, reaching 1.4K.
Neuracle Science Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuracle Science's valuation, stock price, and market status.